Commentaries by date:
By Sheldon Greenfield, MD, University of California, Irvine, IOM Committee Chair Has the development of clinical practice guidelines (CPGs) made meaningful progress since…
Read MoreBy Marguerite Koster, MA, MFT Chair, Guidelines International Network/North America (G-I-N/NA) Practice Leader, Evidence-Based Medicine Services Unit Kaiser Permanente Southern California When the…
Read MoreBy Sandra Zelman Lewis, PhD, Chief Guidelines Officer, Doctor Evidence The importance of high quality double-blinded randomized controlled trials (RCTs) is…
Read MoreBy Craig W Robbins, MD, MPH, Medical Director, Kaiser Permanente National Guideline Program, Trustee G-I-N Board of Trustees Kaiser Permanente‘s mission is to…
Read MoreBy Craig Whittington, PhD, Associate Director (Clinical Effectiveness), NCCMH, Senior Research Fellow, UCL Director, UK GRADE Centre* We live in interesting times. In…
Read MoreBy Sandra Zelman Lewis, PhD, Chief Guidelines Officer, Doctor Evidence Welcome to the inaugural publication of GROWTH Commentaries! This is a regular…
Read More- « Previous
- 1
- …
- 4
- 5
- 6
What a difference a year makes: 1 year after implementing the AHRQ National Guidelines
By Mary P. Nix, MS, PMP Health Scientist Administrator Staff Lead for National Guidelines Clearinghouse and National Quality Measures Clearinghouse Agency for Healthcare Research…
Read More